EUVIMEDEUVIMED entdecken
Crossref

Synthesis and biological evaluation of novel 5‐substituted/unsubstituted triazolothiadiazines as tubulin depolymerizing and vascular disrupting agents with promising antitumor activity

Xian-Sen Huo, Ji Tang-Yang, Wen-Bin Zeng, Xie-Er Jian, Xuan-Xuan Ma, Peng Yue-Yang, You Wen-Wei, Pei-Liang Zhao iD

Drug Development Research · 2023

DOI: 10.1002/ddr.22066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2023. Verfasst von Xian-Sen Huo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Science, Southern Medical University, Guangzhou, P.R.China. Hauptthemen laut MEDLINE: Thiadiazines, Ovarian Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel series of 5‐substituted/unsubstituted [1,2,4]triazolo[3,4‐ b ][1,3,4] thiadiazine compounds has been achieved successfully through chemoselective reduction of the C = N bond, based on our prior work. Initial biological evaluation illustrated that the most active derivative 7j exhibited significant cell growth inhibitory activity toward MCF‐7, A549, HCT116, and A2780 with the IC 50 values of 0.75, 0.94, 2.90, and 4.15 μM, respectively. Most importantly, all the representative analogs did not demonstrate obvious cytotoxic activity against the non‐tumoural cell line HEK‐293 (IC 50 > 100 μM). The mechanism study revealed that 7j caused the G 2 /M phase arrest, induced cell apoptosis in HeLa cells in a concentration‐dependent manner, and also showed potent tubulin polymerization inhibitory effect. Meanwhile, 7j exerted significant antivascular activity in the wound‐healing and tube formation assays. These observations indicate that 5‐unsubstituted 6,7‐dihydro‐5 H ‐[1,2,4]triazolo[3,4‐ b ][1,3,4]thiadiazine scaffold might be considered as a potential lead for antitubulin inhibitors to develop highly efficient anticancer agents with potent selectivity over normal human cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiadiazinesOvarian NeoplasmsAntineoplastic AgentsFemaleHumansStructure-Activity RelationshipMolecular StructureTubulinCell Line, TumorHeLa CellsHEK293 CellsDrug Screening Assays, AntitumorDrug DesignTubulin ModulatorsCell ProliferationApoptosis

Stichwörter der Autor:innen

5-substituted/unsubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinesantiproliferative activitytubulin polymerization

Substanzen

TubulinThiadiazinesTubulin ModulatorsAntineoplastic Agents

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Science, Southern Medical University, Guangzhou, P.R.China.

ORCID-Profile: Pei-Liang Zhao

Zitieren

APA

Huo, X. S., Tang-Yang, J., Zeng, W. B., Jian, X. E., Ma, X. X., Yue-Yang, P., Wen-Wei, Y., & Zhao, P. L. (2023). Synthesis and biological evaluation of novel 5‐substituted/unsubstituted triazolothiadiazines as tubulin depolymerizing and vascular disrupting agents with promising antitumor activity. Drug Development Research. https://doi.org/10.1002/ddr.22066

Vancouver

Huo XS, Tang-Yang J, Zeng WB, Jian XE, Ma XX, Yue-Yang P, et al. Synthesis and biological evaluation of novel 5‐substituted/unsubstituted triazolothiadiazines as tubulin depolymerizing and vascular disrupting agents with promising antitumor activity. Drug Development Research. 2023. doi:10.1002/ddr.22066

BibTeX
@article{Huo2023,
  author = {Huo, Xian-Sen and Tang-Yang, Ji and Zeng, Wen-Bin and Jian, Xie-Er and Ma, Xuan-Xuan and Yue-Yang, Peng and Wen-Wei, You and Zhao, Pei-Liang},
  title = {Synthesis and biological evaluation of novel 5‐substituted/unsubstituted triazolothiadiazines as tubulin depolymerizing and vascular disrupting agents with promising antitumor activity},
  journal = {Drug Development Research},
  year = {2023},
  doi = {10.1002/ddr.22066}
}
Kostenlos starten →